CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
FARAPULSE Endocardial Multi Ablation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04170608
NCT04170608N/ACompleted
CompareCT.gov

PEFCAT II: Expanded Safety and Feasibility Study of the FARAPULSE Endocardial Multi Ablation System to Treat Paroxysmal Atrial Fibrillation

Boston Scientific Corporation·interventional·Posted Nov 20, 2019·Updated May 4, 2022

In Brief

A clinical study evaluating FARAPULSE Endocardial Multi Ablation System for Paroxysmal Atrial Fibrillation. Completed, enrolled 10 participants across 2 sites in 2 countries.

Detailed Summary

PEFCAT II: Expanded Safety and Feasibility Study of the FARAPULSE Endocardial Multi Ablation System to Treat Paroxysmal Atrial Fibrillation

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParoxysmal Atrial Fibrillation
CountriesCroatia, Czechia
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedNov 20, 2019
Enrollment StartOct 18, 2019
Primary CompletionDec 7, 2020
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.6 years ago

Interventions

FARAPULSE Endocardial Multi Ablation Systemdevice

Ablation using the FARAPULSE Endocardial Multi Ablation System